Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target

Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target

US Patent 11242387 · Granted Feb 8, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Systems, methods, and devices for producing interconnects on deformable substrat2025
Weed puller2025
Anti-PD-L1 diabodies and the use thereof2025
Anti-PD-1 antibodies, dosages and uses thereof2025
Compositions and methods for imaging2024
Sedative laced toothpaste2024
Compositions and uses thereof for treating disease or condition2024
Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggress2024
Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggress2024
Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggress2024
Techniques for storing and analyzing data2023
B7-H5, a costimulatory polypeptide2023